Health
Biological E. Limited gets CDSCO Nod to Start Phase III Clinical Trial of its COVID-19 Vaccine Candidate – United News of India
Hyderabad, Apr 24 (UNI) Biological E. Limited (BE), a Hyderabad-based vaccine and pharmaceutical company on Saturday announced that it has successfully completed…
Hyderabad, Apr 24 (UNI) Biological E. Limited (BE), a Hyderabad-based vaccine and pharmaceutical company on Saturday announced that it has successfully completed the Phase I/II clinical trial of its COVID-19 subunit vaccine candidate in India and received the approval to start the Phase III clinical trial from the Central Drugs Standard Control Organization (CDSCO) – Subject Expert Committee (SEC).BE started the Phase I/II Clinical Trial of its COVID-19 Vaccine Candidate in the second week of November…
-
Noosa News19 hours agoBrisbane vs Collingwood live blog: Richmond selects Noah Balta as unbeaten Lions prepare for Magpies test
-
General18 hours agoNT Coalition candidate Lisa Siebert diverges from Jacinta Nampijinpa Price on royal commission call
-
Noosa News21 hours agoPeter Dutton insists there’s enough water for his seven nuclear plants, contradicting shadow frontbencher
-
General20 hours agoCanberra man named as doctor accused of rape after suppression order lifted